This page shows the latest epigenetics news and features for those working in and with pharma, biotech and healthcare.
LSD1, also called KDM1A, is a member of a group of epigenetic proteins that regulate gene expression through chemical modifications of proteins, RNA and DNA.
The researchers found that epigenetic changes play a key role in how cancers adapt and evolve. ... In the first paper, the researchers collected 1, 373 samples from 30 bowel cancers and looked at epigenetic changes as cancers evolved.
STORM Therapeutics, a University of Cambridge spin-out specialising on small molecule therapies targeting RNA epigenetic mechanisms, has been awarded a Biomedical Catalyst grant by Innovate UK. ... Founded in 2015 by Professors Tony Kouzarides and Eric
German biopharma company MorphoSys has announced that it will acquire Constellations Pharmaceuticals, a clinical-stage company with expertise in epigenetics, for a total of $1.7bn. ... We are proud that MorphoSys has recognised the strength of our team,
In the same article, the authors added that the BCG vaccine induces metabolic and epigenetic changes that enhance innate immune response to subsequent infections in a process called ‘trained immunity’.
We are extremely encouraged by the results of the QUAZAR AML-001 study as a part of our continuing commitment to both epigenetic research and myeloid diseases,” said Samit Hariwat, chief
More from news
Approximately 2 fully matching, plus 17 partially matching documents found.
The expansion of Alzheimer’s R&D is underpinned by evidence that the disease has a range of drivers, including Abeta, inflammation and epigenetics, that evolve as it progresses. ... And a host of other academic and industry teams are looking at
licence, collaboration. 207.5. Proterosos biostructures/ Merck &Co (MSD). second collaboration to develop small molecules against an additional epigenetic target for various cancers.
Tensha has developed an epigenetic technology that disrupts bromodomain and extra terminal domain (BET) proteins in order to develop potential treatments for cancer. ... 535. Rodin/ Biogen. Collaboration. Multi-year neuronal epigenetics research
Proteros' epigenetics technology and structure guided discovery platform for oncology targets (discovery).
This situation occurred when Genentech/Roche elected not to go further with their option to acquire the epigenetics drug discovery company, Constellation Pharmaceuticals.
More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.
Epigenetics Research.
mature into a world leading therapeutics company targeting RNA epigenetic modulation.”.
As a clinician-scientist at the University of Melbourne, Professor Dawson has experience in epigenetics having spent several years researching epigenetic regulation of leukaemia stem cells. ... Keith Blundy, chief executive officer of Storm Therapeutics,
RNA epigenetic modulation is an exciting area of science with real potential to deliver new targeted cancer therapies. ... We look forward to Paul’s input on development and positioning of Storm’s emerging RNA epigenetics platform and programmes.”.
He most recently served as the senior vice president and head of the cancer epigenetics department at GlaxoSmithKline, where he was responsible for overall strategy, as well as identification and validation ... of new epigenetic targets and advancing
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...